McKesson PT Raised to $214.00 at Mizuho (MCK)
Equities research analysts at Mizuho lifted their price objective on shares of McKesson (NYSE:MCK) from $205.00 to $214.00 in a research note issued to investors on Thursday. The firm currently has a “buy” rating on the stock. Mizuho’s target price indicates a potential upside of 11.54% from the company’s current price.
A number of other firms have also recently commented on MCK. Analysts at FBR Capital Markets raised their price target on shares of McKesson from $200.00 to $210.00 in a research note on Thursday. They now have an “outperform” rating on the stock. Separately, analysts at Raymond James raised their price target on shares of McKesson from $210.00 to $220.00 in a research note on Tuesday, July 1st. Finally, analysts at Morgan Stanley reiterated an “overweight” rating on shares of McKesson in a research note on Thursday, June 26th. They now have a $205.00 price target on the stock, up previously from $197.00. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $203.73.
McKesson (NYSE:MCK) traded up 0.32% during mid-day trading on Thursday, hitting $191.86. 2,543,320 shares of the company’s stock traded hands. McKesson has a 52 week low of $120.17 and a 52 week high of $195.20. The stock’s 50-day moving average is $188.1 and its 200-day moving average is $178.9. The company has a market cap of $44.238 billion and a P/E ratio of 35.30.
McKesson (NYSE:MCK) last announced its earnings results on Thursday, July 31st. The company reported $2.49 EPS for the quarter, beating the Thomson Reuters consensus estimate of $2.36 by $0.13. The company had revenue of $44.06 billion for the quarter, compared to the consensus estimate of $40.65 billion. During the same quarter in the prior year, the company posted $2.07 earnings per share. The company’s quarterly revenue was up 36.7% on a year-over-year basis. On average, analysts predict that McKesson will post $10.66 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Wednesday, October 1st. Investors of record on Tuesday, September 2nd will be paid a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a dividend yield of 0.50%.
McKesson Corporation delivers pharmaceuticals, medical supplies and healthcare information technologies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.